IndraLab

Statements

EGF sumoylates OTUB2. 10 / 10
| 6 4
reach
"Thus, these clinical data support our model that EGF signaling or RAS activation stimulates OTUB2 SUMOylation and thereby stabilizes YAP/TAZ, which enhances cancer stemness and metastasis ( Figure 7 K[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
30472188
reach
"Moreover, we found that EGF, which can activate RAS, also promotes OTUB2 SUMOylation."
30472188
sparser
"Moreover, OTUB2 poly-SUMOylation was stimulated by epidermal growth factor (EGF) and oncogenic KRAS mutation."
30472188
sparser
"Importantly, EGF and oncogenic KRAS induce OTUB2 poly-SUMOylation and thereby activate YAP/TAZ."
36264492
reach
"Moreover, OTUB2 poly-SUMOylation was stimulated by epidermal growth factor (EGF) and oncogenic KRAS mutation."
30472188
sparser
"Furthermore, OTUB2 sumoylation is stimulated by EGF and oncogenic KRAS, which is essential for EGF and KRAS to stabilize Yap/Taz ( xref )."
33869224
reach
"Therefore, our observations suggest that EGF and RAS activation might be able to regulate YAP/TAZ through SUMOylating OTUB2."
30472188
reach
"Interestingly, the SUMOylation of OTUB2 is induced by EGF and KRAS [78]."
38136274
reach
"Poly-SUMOylated OTUB2, which was induced by Epidermal growth factor (EGF) and oncogenic KRAS, was shown to bind and activate YAP/TAZ promoting tumor metastasis [68]."
31619007
sparser
"Interestingly, the SUMOylation of OTUB2 is induced by EGF and KRAS [ xref ]."
38136274